Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
Eur J Neurosci ; 29(6): 1177-87, 2009 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-19302153

RESUMO

The sedative and hypnotic agent 4,5,6,7-tetrahydroisoxazolo[4,5-c]pyridine-3-ol (THIP) is a GABA(A) receptor (GABA(A)R) agonist that preferentially activates delta-subunit-containing GABA(A)Rs (delta-GABA(A)Rs). To clarify the role of delta-GABA(A)Rs in mediating the sedative actions of THIP, we utilized mice lacking the alpha(1)- or delta-subunit in a combined electrophysiological and behavioural analysis. Whole-cell patch-clamp recordings were obtained from ventrobasal thalamic nucleus (VB) neurones at a holding potential of -60 mV. Application of bicuculline to wild-type (WT) VB neurones revealed a GABA(A)R-mediated tonic current of 92 +/- 19 pA, which was greatly reduced (13 +/- 5 pA) for VB neurones of delta(0/0) mice. Deletion of the delta- but not the alpha(1)-subunit dramatically reduced the THIP (1 mum)-induced inward current in these neurones (WT, -309 +/- 23 pA; delta(0/0), -18 +/- 3 pA; alpha(1) (0/0), -377 +/- 45 pA). Furthermore, THIP selectively decreased the excitability of WT and alpha(1) (0/0) but not delta(0/0) VB neurones. THIP did not affect the properties of miniature inhibitory post-synaptic currents in any of the genotypes. No differences in rotarod performance and locomotor activity were observed across the three genotypes. In WT mice, performance of these behaviours was impaired by THIP in a dose-dependent manner. The effect of THIP on rotarod performance was blunted for delta(0/0) but not alpha(1) (0/0) mice. We previously reported that deletion of the alpha(1)-subunit abolished synaptic GABA(A) responses of VB neurones. Therefore, collectively, these findings suggest that extrasynaptic delta-GABA(A)Rs vs. synaptic alpha(1)-subunit-containing GABA(A)Rs of thalamocortical neurones represent an important molecular target underpinning the sedative actions of THIP.


Assuntos
Agonistas GABAérgicos/farmacologia , Isoxazóis/farmacologia , Inibição Neural/efeitos dos fármacos , Receptores de GABA-A/fisiologia , Tálamo/efeitos dos fármacos , Análise de Variância , Animais , Animais Recém-Nascidos , Bicuculina/farmacologia , Relação Dose-Resposta a Droga , Estimulação Elétrica/métodos , Feminino , Antagonistas GABAérgicos/farmacologia , Glicinérgicos/farmacologia , Técnicas In Vitro , Locomoção/efeitos dos fármacos , Locomoção/genética , Masculino , Camundongos , Camundongos Endogâmicos C57BL , Camundongos Knockout , Atividade Motora/efeitos dos fármacos , Atividade Motora/genética , Inibição Neural/genética , Técnicas de Patch-Clamp/métodos , Receptores de GABA-A/deficiência , Receptores de GABA-A/genética , Estricnina/farmacologia , Fatores de Tempo
2.
Brain Res Dev Brain Res ; 160(1): 85-9, 2005 Nov 07.
Artigo em Inglês | MEDLINE | ID: mdl-16154637

RESUMO

Hyperhomocysteinemia is a risk factor for a range of neurodegenerative conditions, yet its effects in the developing nervous system have been poorly elucidated. We studied the in vitro response of cerebellar granule neurons (CGCs) to homocysteine. We have shown that embryonic CGCs are resistant to homocysteine-induced neurotoxicity, whilst postnatal CGCs are not. This is the first demonstration of a neuronal population undergoing a developmental switch in their response to homocysteine. Greater understanding of this change may have important implications for both neurodegenerative conditions and neurodevelopmental disorders.


Assuntos
Envelhecimento/metabolismo , Homocisteína/metabolismo , Hiper-Homocisteinemia/complicações , Necrose/induzido quimicamente , Doenças Neurodegenerativas/metabolismo , Neurônios/metabolismo , Animais , Animais Recém-Nascidos , Células Cultivadas , Suscetibilidade a Doenças/metabolismo , Suscetibilidade a Doenças/fisiopatologia , Homocisteína/toxicidade , Camundongos , Microscopia Eletrônica de Transmissão , Necrose/metabolismo , Necrose/patologia , Doenças Neurodegenerativas/etiologia , Doenças Neurodegenerativas/fisiopatologia , Neurônios/efeitos dos fármacos , Neurônios/patologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA